[go: up one dir, main page]

AR072566A1 - Metodos para el tratamiento de infecciones en la cavidad oral con dioxido de cloro - Google Patents

Metodos para el tratamiento de infecciones en la cavidad oral con dioxido de cloro

Info

Publication number
AR072566A1
AR072566A1 ARP090102707A ARP090102707A AR072566A1 AR 072566 A1 AR072566 A1 AR 072566A1 AR P090102707 A ARP090102707 A AR P090102707A AR P090102707 A ARP090102707 A AR P090102707A AR 072566 A1 AR072566 A1 AR 072566A1
Authority
AR
Argentina
Prior art keywords
methods
chlorine dioxide
oral cavity
infections
treatment
Prior art date
Application number
ARP090102707A
Other languages
English (en)
Original Assignee
Basf Catalysts Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Catalysts Llc filed Critical Basf Catalysts Llc
Publication of AR072566A1 publication Critical patent/AR072566A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos, dispositivos, composiciones, y sistemas para el alivio de las infecciones de tejido oral por medio de la administracion de dioxido de cloro. Reivindicacion 5: El método de la reivindicacion 1, caracterizado porque la infeccion del tejido de la cavidad oral se selecciona de entre el grupo que consta de halitosis, gingivitis, periodontitis, desarrollo de caries, y afta. Reivindicacion 6: El método de la reivindicacion 1, caracterizado porque la composicion comprende además un agente antimicrobiano. Reivindicacion 7: El método de la reivindicacion 6, caracterizado porque el agente antimicrobiano se selecciona de entre el grupo que consta de doxociclina, metronidazol, clorohexidina, minociclina, tetraciclina, nistatina, miconazol, y anfotericina.
ARP090102707A 2008-07-15 2009-07-16 Metodos para el tratamiento de infecciones en la cavidad oral con dioxido de cloro AR072566A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13501108P 2008-07-15 2008-07-15
US10602608P 2008-10-16 2008-10-16
US15068509P 2009-02-06 2009-02-06
US18719809P 2009-06-15 2009-06-15
US12/502,913 US8293283B2 (en) 2008-07-15 2009-07-14 Methods for treating oral cavity infections with chlorine dioxide

Publications (1)

Publication Number Publication Date
AR072566A1 true AR072566A1 (es) 2010-09-08

Family

ID=41168773

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090102704A AR072516A1 (es) 2008-07-15 2009-07-16 Metodos, sistemas y dispositivos para la administracion de dioxido de cloro a un tejido
ARP090102707A AR072566A1 (es) 2008-07-15 2009-07-16 Metodos para el tratamiento de infecciones en la cavidad oral con dioxido de cloro

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP090102704A AR072516A1 (es) 2008-07-15 2009-07-16 Metodos, sistemas y dispositivos para la administracion de dioxido de cloro a un tejido

Country Status (12)

Country Link
US (4) US20100112059A1 (es)
EP (2) EP2313064A2 (es)
JP (2) JP2011528361A (es)
KR (2) KR20110039461A (es)
CN (2) CN102149363A (es)
AR (2) AR072516A1 (es)
BR (2) BRPI0916446A2 (es)
CA (2) CA2730756A1 (es)
CL (2) CL2009001579A1 (es)
MX (2) MX2011000540A (es)
TW (2) TW201016136A (es)
WO (2) WO2010009140A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8926951B2 (en) * 2007-07-09 2015-01-06 Micropure, Inc. Composition for preventing oral disease by penetrating polymicrobial oral biofilms and killing oral pathogens
KR20110039461A (ko) * 2008-07-15 2011-04-18 바스프 코포레이션 이산화염소 투여를 위한 방법, 시스템 및 장치
US20100196512A1 (en) * 2009-02-04 2010-08-05 Basf Catalyst Llc Treatment of Non-Oral Biological Tissue with Chlorine Dioxide
US20100233101A1 (en) 2009-02-13 2010-09-16 Micropure, Inc. Composition and method for the oxidative consumption of salivary biomolecules
US9101562B2 (en) 2010-01-31 2015-08-11 Basf Corporation Additives for chlorine dioxide-containing compositions
US9711744B2 (en) 2012-12-21 2017-07-18 3M Innovative Properties Company Patterned structured transfer tape
US9745820B2 (en) * 2015-04-28 2017-08-29 Thru Tubing Solutions, Inc. Plugging device deployment in subterranean wells
US20180206960A1 (en) * 2015-07-22 2018-07-26 Cao Group, Inc. Dental treatment films incorporating unmixed reactive ingredients
JP7036360B2 (ja) * 2017-08-30 2022-03-15 岡山県 次亜塩素酸流体の製造方法
CA3020197C (en) 2017-09-01 2024-06-04 Micropure, Inc. Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions
US20200046629A1 (en) * 2018-08-10 2020-02-13 Colgate-Palmolive Company Whitening Compositions and Methods for the Same
CN117401649B (zh) * 2023-12-15 2024-03-08 山东华实药业有限公司 纯净免活化稳定性二氧化氯溶液

Family Cites Families (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2071091A (en) * 1936-07-13 1937-02-16 Mathieson Alkali Works Inc Chemical manufacture
SE392582B (sv) * 1970-05-21 1977-04-04 Gore & Ass Forfarande vid framstellning av ett porost material, genom expandering och streckning av en tetrafluoretenpolymer framstelld i ett pastabildande strengsprutningsforfarande
US4060600A (en) * 1972-10-26 1977-11-29 National Patent Development Corporation Treating teeth
GB1579431A (en) * 1976-03-23 1980-11-19 Minnesota Mining & Mfg Disinfecting and/or sterilising
US4330531A (en) * 1976-03-26 1982-05-18 Howard Alliger Germ-killing materials
JPS60105610A (ja) * 1983-11-14 1985-06-11 Mitsuru Tsuchikura 口中歯磨剤に添加する安定化二酸化塩素剤
US4671972A (en) * 1984-03-16 1987-06-09 Warner-Lambert Company Controlled release encapsulated hypochlorite deactivator for use in denture cleansers
US4585482A (en) * 1984-05-25 1986-04-29 Southern Research Institute Long-acting biocidal compositions and method therefor
US4696811A (en) * 1984-07-30 1987-09-29 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4793989A (en) * 1984-07-30 1988-12-27 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4689215A (en) * 1984-07-30 1987-08-25 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4837009A (en) * 1986-03-31 1989-06-06 Ratcliff Perry A Method and composition for prevention of plaque formation and plaque dependent diseases
US4788053A (en) * 1984-07-30 1988-11-29 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4855135A (en) * 1984-07-30 1989-08-08 Ratcliff Perry A Method for debriding
US4975285A (en) * 1984-07-30 1990-12-04 Ratcliff Perry A Method for cleaning dental prosthetic devices
US4889714A (en) * 1984-07-30 1989-12-26 Ratcliff Perry A Method for retarding dental plaque by killing streptococcus sanguis
US4886657A (en) * 1984-07-30 1989-12-12 Ratcliff Perry A Method for preventing periodontitis
US4818519A (en) * 1986-12-29 1989-04-04 Ratcliff Perry A Method and composition for prevention of plaque formation and plaque dependent diseases
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4683039A (en) * 1985-12-24 1987-07-28 Tenneco Canada Inc. (Erco Division) Membrane pervaporation process
US4925656A (en) * 1986-03-31 1990-05-15 Ratcliff Perry A Method for retarding formation of dental plaque
US4786492A (en) * 1986-03-31 1988-11-22 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4792442A (en) * 1986-03-31 1988-12-20 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US4851213A (en) * 1986-03-31 1989-07-25 Ratcliff Perry A Method and composition for prevention and treatment of oral disease due to S. Sanguis
US5200171A (en) * 1990-11-20 1993-04-06 Micropure, Inc. Oral health preparation and method
US4808389A (en) * 1986-12-29 1989-02-28 Ratcliff Perry A Method and composition for prevention and treatment of oral disease
US5348734A (en) * 1990-11-20 1994-09-20 Micropure Inc. Oral health preparation and method
US4945125A (en) * 1987-01-05 1990-07-31 Tetratec Corporation Process of producing a fibrillated semi-interpenetrating polymer network of polytetrafluoroethylene and silicone elastomer and shaped products thereof
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4832009A (en) * 1987-12-23 1989-05-23 Bio Med Sciences, Inc. Semi-interpenetrating network polymer backsheet bandage
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US5227168A (en) * 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
US5281412A (en) * 1991-12-30 1994-01-25 The Procter & Gamble Company Oral compositions
US5407656A (en) * 1992-03-04 1995-04-18 Arco Research Co., Inc. Method and compositions for the production of chlorine dioxide
US5719100A (en) * 1992-03-20 1998-02-17 Zahradnik; Rudolf Water treatment compositions
GB9206244D0 (en) * 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
IL102627A (en) * 1992-07-23 1996-05-14 Abic Ltd Solid composition releasing chlorine dioxide
US6046243A (en) * 1993-02-12 2000-04-04 Bernard Technologies, Inc. Compositions for sustained release of a gas
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US6200557B1 (en) * 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
US5489435A (en) * 1993-07-06 1996-02-06 Ratcliff; Perry A. Composition for treatment of abnormal conditions of the epithelium of bodily orifices
US5526841A (en) * 1993-08-20 1996-06-18 Detsch; Steven G. Water line decontamination system
US5656279A (en) * 1994-02-23 1997-08-12 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
WO1995027472A1 (en) * 1994-04-07 1995-10-19 Richter Jon L Oral rinse and method of treating halitosis
US5597561A (en) * 1994-12-14 1997-01-28 Alcide Corporation Adherent disinfecting compositions and methods of use in skin disinfection
GB2300423A (en) * 1995-03-27 1996-11-06 Jeyes Group Plc Lavatory cleansing
ATE438444T1 (de) * 1995-09-25 2009-08-15 Discus Dental Llc Zahnbleichende zusammensetzungen
JP2000516221A (ja) * 1996-07-29 2000-12-05 モンゴメリー、ロバート・エリック 二酸化塩素歯白色化組成物
US5820822A (en) * 1996-10-25 1998-10-13 Kross; Robert D. Antimicrobial composition and method of use
US6077495A (en) * 1997-03-03 2000-06-20 Engelhard Corporation Method, composition and system for the controlled release of chlorine dioxide gas
US6007735A (en) * 1997-04-30 1999-12-28 Ecolab Inc. Coated bleach tablet and method
US5879691A (en) * 1997-06-06 1999-03-09 The Procter & Gamble Company Delivery system for a tooth whitener using a strip of material having low flexural stiffness
US6096328A (en) * 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
US6630937B2 (en) * 1997-10-30 2003-10-07 University Of South Florida Workstation interface for use in digital mammography and associated methods
US6365131B1 (en) * 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
JP4478326B2 (ja) * 1997-11-07 2010-06-09 バスフ・カタリスツ・エルエルシー 二酸化塩素を含有する水溶液を製造するための方法および装置
US6077502A (en) * 1998-02-27 2000-06-20 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6039934A (en) * 1998-08-04 2000-03-21 Alliger; Howard Use of xanthan gum for gelling CIO2 and related species
DE19854349A1 (de) 1998-11-25 2000-05-31 Up To Dent Ag Balzers Mundpflegemittel
US6106284A (en) * 1999-01-15 2000-08-22 Cronin; Richard J. Dental cast tray assembly
US7273567B1 (en) * 1999-11-24 2007-09-25 Microactive Corp. Energy-activated compositions for controlled sustained release of a gas
US6280775B1 (en) * 1999-06-09 2001-08-28 Joseph Alan Sasson Antimicrobial oral composition and method of use
ATE285220T1 (de) * 1999-07-02 2005-01-15 Procter & Gamble Zusammenstzungen enthaltend organosiloxan-harze zur freisetzung von mundpflegewirkstoffen und zur verlängerung der freisetzung
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US6379658B1 (en) * 1999-12-21 2002-04-30 International Flavors & Fragrances Inc. Human sweat malodor counteractant composition and process for using same
US6432322B1 (en) * 2000-02-02 2002-08-13 Engelhard Corporation Massive bodies for producing highly converted solutions of chlorine dioxde
US20060169949A1 (en) * 2000-02-02 2006-08-03 Speronello Barry K Massive bodies containing free halogen source for producing highly converted thickened solutions of chlorine dioxide
ES2320321T3 (es) * 2000-03-17 2009-05-21 LG HOUSEHOLD & HEALTH CARE LTD. Parches para blanquear dientes.
US6432387B1 (en) * 2000-03-23 2002-08-13 Create Co., Ltd. Ionic tooth polishing agent
US6582682B2 (en) * 2000-10-30 2003-06-24 Noville, Inc. Oral care compositions comprising stabilized chlorine dioxide
US6425759B1 (en) * 2000-11-15 2002-07-30 Richard J. Cronin Dental cast tray assembly
JP3957195B2 (ja) * 2001-01-24 2007-08-15 ブライトスマイル プロフェッショナル インク． 局所用口腔ケア組成物
US6500408B2 (en) * 2001-01-27 2002-12-31 Jc Technologies, Inc. Enamel-safe tooth bleach and method for use
US6514484B2 (en) * 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
US6669931B2 (en) * 2001-03-29 2003-12-30 Curozone Ireland Limited Formulation for the remineralization of teeth
US20030235549A1 (en) * 2001-05-01 2003-12-25 Parminder Singh Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US7087208B2 (en) * 2001-08-02 2006-08-08 Sampson Allison H Methods for making chlorous acid and chlorine dioxide
US6759030B2 (en) * 2002-03-21 2004-07-06 Carl M. Kosti Bleach stable toothpaste
US20040009138A1 (en) * 2002-05-20 2004-01-15 Kling William O. Skin cleanser compositions and methods of use
US20030228264A1 (en) * 2002-06-06 2003-12-11 Perna Salvatore F. Dissolvable teeth whitening apparatus
US6896518B2 (en) * 2002-06-28 2005-05-24 Scott Jacobs Teeth treatment device
US7029705B2 (en) * 2002-07-30 2006-04-18 Fuhr Allan H Nasal hygiene method and composition
US6848905B2 (en) * 2002-08-20 2005-02-01 Archtek, Inc. Method of making a dental tray using a patient's teeth as a template
US6881061B2 (en) * 2002-09-30 2005-04-19 Mcneil-Ppc, Inc. Ultrasonic method for cleaning teeth
US6964571B2 (en) * 2003-01-24 2005-11-15 Ultradent Products, Inc. Pre-shaped dental trays and treatment devices and methods that utilize such dental trays
US7004756B2 (en) * 2003-01-24 2006-02-28 Ultradent Products, Inc. Pre-shaped dental trays and treatment devices and methods that utilize such dental trays
US7087190B2 (en) * 2003-03-20 2006-08-08 Ecolab Inc. Composition for the production of chlorine dioxide using non-iodo interhalides or polyhalides and methods of making and using the same
US7252096B2 (en) * 2003-04-08 2007-08-07 Nalco Company Methods of simultaneously cleaning and disinfecting industrial water systems
US7040897B2 (en) * 2003-05-23 2006-05-09 Ultradent Products, Inc. Thin, flexible membrane dental trays and systems and methods utilizing such trays
US8137581B2 (en) * 2003-08-04 2012-03-20 Basf Corporation Chlorine dioxide releasing composite article
US7229647B2 (en) * 2003-10-09 2007-06-12 Sunggyu Lee Chlorine dioxide gel and associated methods
US20060183080A1 (en) * 2003-11-21 2006-08-17 Vasiliy Nosov Dental treatment kits and methods for forming customized dental trays
US20050137109A1 (en) * 2003-12-17 2005-06-23 The Procter & Gamble Company Emulsion composition for delivery of bleaching agents to teeth
US7059858B2 (en) * 2004-02-19 2006-06-13 Ultradent Products, Inc. Universal tray design having anatomical features to enhance fit
US7044737B2 (en) * 2004-03-05 2006-05-16 Liang Fu Ultrasound oral hygiene and therapeutic device
US7383946B2 (en) * 2004-03-26 2008-06-10 Hughes Kenneth D Materials for storing and releasing reactive gases
US20060006361A1 (en) * 2004-07-08 2006-01-12 Joseph Callerame Clathrate of chlorine dioxide
US20060045855A1 (en) * 2004-09-02 2006-03-02 Sasson J A Oral composition for reducing plaque and microbial infections and whitening teeth
US7497834B2 (en) * 2004-10-22 2009-03-03 General Patent Llc Germicidal method for eradicating or preventing the formation of biofilms
US20060088498A1 (en) * 2004-10-27 2006-04-27 Truox, Inc. Anti-microbial composition using in-situ generation of an oxidizing agent
US20060099550A1 (en) * 2004-11-10 2006-05-11 Ranir/Dcp Corporation Device and method for delivering an oral care agent
US7514019B2 (en) * 2005-03-01 2009-04-07 Truox, Inc. Solvent-activated reactor including a gel layer
US7534368B2 (en) * 2005-03-01 2009-05-19 Truox, Inc. Oxidizing composition including a gel layer
EP1885325A1 (en) * 2005-04-11 2008-02-13 Remedent NV Foam strip for the delivery of oral care compositions
US20080209650A1 (en) * 2005-05-03 2008-09-04 Ultreo, Inc. Oral hygiene devices
US20060263306A1 (en) * 2005-05-19 2006-11-23 Pauline Pan Compositions having improved substantivity
US20060292092A1 (en) * 2005-06-22 2006-12-28 Deepak Sharma Oral care compositions, devices, and methods of using the same
US20060292090A1 (en) * 2005-06-22 2006-12-28 Deepak Sharma Oral care compositions, devices, and methods of using the same
AU2006332600B2 (en) 2005-11-14 2011-10-13 Cdg Environmental, Llc. Storage-stable aqueous solutions of chlorine dioxide and methods for preparing and using them
JP5203959B2 (ja) 2005-11-22 2013-06-05 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 発泡基材およびその製造方法
US20070172412A1 (en) * 2006-01-26 2007-07-26 Linda Hratko Thickened fluid composition comprising chlorine dioxide
CN101431940B (zh) * 2006-02-24 2013-03-27 纳微振动技术公司 用于对皮肤进行声表面波处置的系统和方法
US8673297B2 (en) * 2006-02-28 2014-03-18 Basf Corporation Chlorine dioxide based cleaner/sanitizer
US20070231277A1 (en) * 2006-03-31 2007-10-04 Deepak Sharma Multicomponent whitening compositions and containers
GB0609485D0 (en) 2006-05-12 2006-06-21 Glaxo Group Ltd Chlorine dioxide tooth whitening composition
US20070298380A1 (en) * 2006-06-26 2007-12-27 Ultradent Products, Inc. Dental treatment devices adapted for improved lingual side adhesion
US8865192B2 (en) * 2006-07-07 2014-10-21 The Procter & Gamble Co Flavor oils with reduced sulfur content and use in oral care compositions
US20080020064A1 (en) * 2006-07-21 2008-01-24 Advanced Vision Research Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
US9067082B2 (en) * 2006-07-26 2015-06-30 Ultradent Products, Inc. Dental bleaching compositions having long-term rheological stability and devices, kits and methods that utilize such compositions
US20080041400A1 (en) * 2006-08-17 2008-02-21 Darnell Daniel H System and Process for Custom Molding Dental Trays
WO2008040020A2 (en) * 2006-09-28 2008-04-03 Puricore, Inc. Apparatus and method for wound, cavity, and bone treatment
US20080208179A1 (en) * 2006-10-26 2008-08-28 Reliant Technologies, Inc. Methods of increasing skin permeability by treatment with electromagnetic radiation
ES2633020T3 (es) * 2006-12-10 2017-09-18 Yu, Chongxi-Techfields Biochem Sistemas de administración transdérmica de antibióticos betalactámicos
US20090016973A1 (en) * 2007-07-09 2009-01-15 Micropure, Inc. Composition and Method for the Prevention of Oral Disease
US7875460B2 (en) * 2007-07-09 2011-01-25 Micropure, Inc. Method for determining the effectiveness of stabilized chlorine dioxide in a mouth rinse
US8926951B2 (en) * 2007-07-09 2015-01-06 Micropure, Inc. Composition for preventing oral disease by penetrating polymicrobial oral biofilms and killing oral pathogens
US9320921B2 (en) * 2008-12-22 2016-04-26 Karen C. Swenholt Nail fungus treatment and composition
US20100009009A1 (en) * 2008-07-10 2010-01-14 Micropure, Inc. Method and composition for prevention and treatment of oral fungal infections
US20100012892A1 (en) * 2008-07-15 2010-01-21 Basf Catalysts Llc Tooth Whitening Compositions and Methods
KR20110039461A (ko) * 2008-07-15 2011-04-18 바스프 코포레이션 이산화염소 투여를 위한 방법, 시스템 및 장치
US8697141B2 (en) * 2008-08-26 2014-04-15 Micropure, Inc. Method and composition for preventing and healing osteonecrosis of the jaw
ES2385236B8 (es) * 2008-12-22 2014-01-31 Micropure Inc. Composición y método para reducir la desmineralización de los dientes.
US20100196512A1 (en) * 2009-02-04 2010-08-05 Basf Catalyst Llc Treatment of Non-Oral Biological Tissue with Chlorine Dioxide
US20100233101A1 (en) * 2009-02-13 2010-09-16 Micropure, Inc. Composition and method for the oxidative consumption of salivary biomolecules

Also Published As

Publication number Publication date
CN102123694A (zh) 2011-07-13
TW201016247A (en) 2010-05-01
KR20110039461A (ko) 2011-04-18
AR072516A1 (es) 2010-09-01
US20100112059A1 (en) 2010-05-06
MX2011000540A (es) 2011-08-17
TW201016136A (en) 2010-05-01
CA2741231A1 (en) 2010-01-21
US20100015207A1 (en) 2010-01-21
WO2010009140A2 (en) 2010-01-21
CA2730756A1 (en) 2010-01-21
BRPI0916250A2 (pt) 2015-11-03
CL2009001579A1 (es) 2011-07-22
US8293283B2 (en) 2012-10-23
US20100062043A1 (en) 2010-03-11
WO2010009200A3 (en) 2010-03-11
WO2010009140A3 (en) 2010-04-01
MX2011000538A (es) 2011-08-12
US20100062042A1 (en) 2010-03-11
CL2009001600A1 (es) 2012-02-10
CN102123694B (zh) 2013-07-31
BRPI0916446A2 (pt) 2018-09-11
EP2313067A2 (en) 2011-04-27
KR20110042310A (ko) 2011-04-26
CN102149363A (zh) 2011-08-10
JP2011528367A (ja) 2011-11-17
EP2313064A2 (en) 2011-04-27
WO2010009200A2 (en) 2010-01-21
JP2011528361A (ja) 2011-11-17

Similar Documents

Publication Publication Date Title
AR072566A1 (es) Metodos para el tratamiento de infecciones en la cavidad oral con dioxido de cloro
CL2008000895A1 (es) Composición para el cuidado oral que comprende un aminoácido fundamental; una fracción de partículas pequeñas y un agente antimicrobiano y su uso para reducir o prevenir las caries dentales, lesiones del esmalte, desmineralización, hipersensibilidad dental, gingivitis, entre otras.
CL2008000892A1 (es) Composicion para el cuidado bucal que comprende un aminoacido basico en forma de salo libre, un tensoactivo anionico, un agente antibacteriano, una fuente de floruro; un polimero anionico y combinaciones de estos; uso para reducir o inhibir la formacion de caries dentales y lesiones tempranas del esmalte, entre otras.
AR071183A1 (es) Composicion oral que comprende un componente activo y un componente formador de pelicula adhesiva, metodo
MX343075B (es) Composiciones y metodos fotoactivables que desprenden oxigeno para el blanqueamiento dental.
AR058645A1 (es) Composiciones orales que comprenden propoleo
AR073345A1 (es) Composiciones y metodos para el blanqueamiento dental
BR112012010992A2 (pt) formulação de gel de polissacarídeo tendo distribuição de agente bioativo em estágios múltiplos
CL2009001844A1 (es) Forma de dosificacion farmaceutica solida que comprende lopinavir y ritonavir formulados en forma de dispersion solida o solucion solida, un polimero soluble en agua y un tensioactivo con valores de hlb de entre 4 y 10, util en el tratamiento de una infeccion por vih (divisional sol. 393-06).
CL2009000625A1 (es) Composicion farmaceutica que comprende a)un primer poliol seleccionado de manitol, sorbitol o una combinacion de ambos, b)segundo poliol seleccionado de propilenglicol, glicerina o una combinacion de ambas, c)complejo de borato en un 0,5% p/v de la composicion total, d)preservante, e)agua; util para el tratamiento del ojo.
AR060739A1 (es) Composiciones orales que comprenden polimeros de siloxano
AR068379A1 (es) Composiciones dentrificas para tratar xerostomia. metodo de tratamiento
AR045068A1 (es) Formulacion de liberacion inmediata de composiciones farmaceuticas
UY28431A1 (es) Peliculas que se disuelven por via oral
MX354123B (es) Composición antiséptica oral para tratamiento de mucositis oral.
CL2008001533A1 (es) Formulacion que comprende triazinonas y compuestos o complejos ferricos, utiles para preparar medicamentos para uso veterinario contra la coccidiosis y deficiencias de hierro.
TW201436816A (zh) 口腔保健組成物
EA202191211A1 (ru) Композиции и способы для обработки транзиторных биопленок
MX2021009108A (es) Nanoproductos microbicidas y microbiostaticos de amplio espectro y formulaciones, preparaciones y metodos para su uso.
JP2015515991A5 (es)
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
MX2018007048A (es) Composiciones para el cuidado bucal que comprenden al menos un copolimero de fosfato / acrilato y al menos un ingrediente activo cationico.
ECSP099691A (es) Composición anestésica nanoparticulada para la administración tópica
PT115361A (pt) Composições e métodos para impressão em 3d de matrizes fibrosas com propriedades antimicrobianas incorporando óxido de grafeno e poli (e-caprolactona)
MX2018002892A (es) Composiciones para blanqueamiento dental que comprenden cloruro de cetilpiridinio.

Legal Events

Date Code Title Description
FB Suspension of granting procedure